STOCK MARKET BSE NSE

India's current COVID surge not leading to severe illness, deaths: ICMR chief Dr Balram Bhargava

About the COVID tests, ICMR chief Dr Balram Bhargava said that an increasing trend of home covid tests has been observed in this current surge.

Published: 21st January 2022 08:28 AM  |   Last Updated: 21st January 2022 08:28 AM   |  A+A-

Delhi Coronavirus

For representational purposes (Photo | EPS)

By IANS

NEW DELHI: The current upsurge in Covid cases is not causing severe illness and deaths following the high uptake of Covid vaccines, Indian Council of Medical Research chief Dr Balram Bhargava said on Thursday.

Adressing the media on current Covid surge, he said that the vaccine remains beneficial and deaths have considerably reduced as compared to the second Covid surge.

ALSO READ: Recovered patients warn against Omicron, say ‘long Covid’ a reality

"Vaccines have remained beneficial in India. Deaths have considerably reduced due to vaccinations. In this third surge of Covid-19, we are currently not witnessing severe illness and deaths due to high vaccination uptake," he said.

However, those with comorbidities must monitor their health and avoid any complications, he added.

"Vaccine prevents death and therefore is a must. Deaths are very low in this wave because of very high uptake of Covid vaccines which is 94 per cent of first dose in adults and 72 per cent full dose in the country," Dr Bhargava said.

ALSO READ: Over-the-counter drug sales see surge amid third wave of COVID-19 in Karnataka

About the Covid tests, he said that an increasing trend of home covid tests has been observed in this current surge. "In these 20 days of the year, we have seen 2 lakhs home tests," he added.

NITI Aayog's Member, Health, Dr V.K. Paul, said that the overall 16 per cent positivity in the country is very high. Some states even have reported over 50 per cent positivity like Goa. Kerala has 42 per cent, while Rajasthan has 31 per cent positivity rate. Himachal Pradesh has around 30 per cent Covid positivity rate.

Emphasising the role of vaccination to prevent infection, Dr Paul said that mortality has largely been reduced but the comorbid patients are still major concern.

ALSO READ: Omicron fear driving people to hospitals in Kerala

"In relatively low mortality phase of pandic, comorbidities are most vulnerable, so precautions doses must be administered to the eligible population," he added.

Around 10 per cent population over 60 plus are still due for the first dose, while 25 per cent are due for the second dose of vaccines, he added while asking to get the vaccine administered on the time. He also asked healthcare workers and frontline workers to come for their precautionary doses.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp